NIM
HQL

Needham Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History

Needham Investment Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.99M Buy
429,573
+26,209
+6% +$438K 0.36% 75
2025
Q4 		$6.77M Hold
403,364
– – 0.43% 63
2025
Q3 		$6.26M Buy
403,364
+11,789
+3% +$161K 0.44% 63
2025
Q2 		$5.02M Buy
391,575
+12,921
+3% +$159K 0.4% 65
2025
Q1 		$4.81M Buy
378,654
+25,935
+7% +$351K 0.45% 65
2024
Q4 		$4.63M Hold
352,719
– – 0.36% 76
2024
Q3 		$5.32M Buy
352,719
+10,904
+3% +$165K 0.41% 68
2024
Q2 		$4.84M Buy
341,815
+11,586
+4% +$157K 0.4% 68
2024
Q1 		$4.5M Buy
330,229
+16,437
+5% +$227K 0.42% 66
2023
Q4 		$4.22M Hold
313,792
– – 0.53% 55
2023
Q3 		$3.91M Buy
313,792
+7,862
+3% +$103K 0.67% 47
2023
Q2 		$4.14M Buy
305,930
+6,898
+2% +$95.2K 0.68% 44
2023
Q1 		$4.17M Hold
299,032
– – 0.72% 44
2022
Q4 		$4.25M Sell
299,032
-150,968
-34% -$2.19M 0.77% 43
2022
Q3 		$6.15M Hold
450,000
– – 1.2% 28
2022
Q2 		$6.4M Hold
450,000
– – 1.2% 28
2022
Q1 		$7.44M Hold
450,000
– – 1.08% 28
2021
Q4 		$8.65M Hold
450,000
– – 1.09% 34
2021
Q3 		$9.36M Hold
450,000
– – 1.25% 27
2021
Q2 		$9.65M Sell
450,000
-25,000
-5% -$505K 1.41% 25
2021
Q1 		$9.36M Hold
475,000
– – 1.28% 31
2020
Q4 		$9.38M Sell
475,000
-10,000
-2% -$185K 1.57% 20
2020
Q3 		$8.53M Sell
485,000
-5,000
-1% -$89.5K 1.7% 18
2020
Q2 		$8.8M Sell
490,000
-5,000
-1% -$85.7K 1.88% 16
2020
Q1 		$7.42M Sell
495,000
-7,359
-1% -$120K 2.1% 13
2019
Q4 		$8.76M Hold
502,359
– – 2.39% 14
2019
Q3 		$7.59M Sell
502,359
-17,500
-3% -$280K 2.44% 16
2019
Q2 		$8.76M Sell
519,859
-12,500
-2% -$206K 2.89% 11
2019
Q1 		$9.12M Sell
532,359
-6,000
-1% -$104K 3.1% 11
2018
Q4 		$8.13M Hold
538,359
– – 3.05% 11
2018
Q3 		$11M Sell
538,359
-3,366
-0.6% -$67K 3.31% 9
2018
Q2 		$10.2M Hold
541,725
– – 2.86% 12
2018
Q1 		$10.4M Buy
541,725
+2,000
+0.4% +$40.1K 2.98% 12
2017
Q4 		$10.6M Sell
539,725
-10,581
-2% -$212K 2.82% 11
2017
Q3 		$11.8M Sell
550,306
-2,500
-0.5% -$53.1K 2.99% 12
2017
Q2 		$11.5M Sell
552,806
-22,317
-4% -$451K 3.07% 10
2017
Q1 		$11.2M Buy
575,123
+38,531
+7% +$714K 2.87% 11
2016
Q4 		$9.12M Buy
536,592
+12,257
+2% +$215K 2.33% 13
2016
Q3 		$9.82M Buy
524,335
+21,403
+4% +$403K 2.59% 12
2016
Q2 		$8.64M Buy
502,932
+9,435
+2% +$174K 2.39% 11
2016
Q1 		$8.85M Buy
493,497
+14,354
+3% +$261K 2.31% 12
2015
Q4 		$11.3M Buy
479,143
+9,109
+2% +$226K 2.82% 9
2015
Q3 		$10.6M Sell
470,034
-4,800
-1% -$134K 2.65% 10
2015
Q2 		$13.4M Sell
474,834
-100,200
-17% -$2.78M 2.9% 8
2015
Q1 		$15.9M Sell
575,034
-47,563
-8% -$1.3M 3.38% 6
2014
Q4 		$15.5M Hold
622,597
– – 3.26% 7
2014
Q3 		$13.8M Buy
622,597
+12,473
+2% +$271K 3.04% 8
2014
Q2 		$12.7M Buy
610,124
+159,529
+35% +$3.35M 2.64% 11
2014
Q1 		$9.8M Hold
450,595
– – 2.07% 15
2013
Q4 		$9.21M Buy
450,595
+8,577
+2% +$166K 1.91% 16
2013
Q3 		$8.51M Buy
442,018
+7,856
+2% +$150K 1.9% 20
2013
Q2 		$7.76M Buy
+434,162
New +$7.84M 1.81% 22

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Needham Investment Management's HQL Position: Q1 2026 in Review

Needham Investment Management increased its abrdn Life Sciences Investors (HQL) stake by 6.5% in Q1 2026, buying an estimated $438K and bringing the position to 429,573 shares worth $6.99M. The position accounts for 0.36% of the portfolio, ranked #75.

Needham Investment Management first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.9M in Q1 2015. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Needham Investment Management held 429,573 shares of abrdn Life Sciences Investors worth $6.99M as of Q1 2026.
  • Needham Investment Management bought 26,209 abrdn Life Sciences Investors shares in Q1 2026, an estimated $438K.
  • abrdn Life Sciences Investors made up 0.36% of Needham Investment Management's portfolio in Q1 2026, its #75 holding.
  • Needham Investment Management first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • Needham Investment Management's abrdn Life Sciences Investors position peaked at $15.9M in Q1 2015.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Needham Investment Management's 13F filing for Q1 2026, filed 15 May 2026.